Markets:

Overview

News

Currencies

International

Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

60.23 +1.81 (+3.10%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

43 44 Next >

$100 Invested In This Stock 15 Years Ago Would Be Worth $21,000 Today ↗

December 21, 2023

Via Benzinga

DexCom's Options Frenzy: What You Need to Know ↗

December 20, 2023

Via Benzinga

Dexcom to Present at 42nd Annual J.P. Morgan Healthcare Conference

December 19, 2023

From DexCom, Inc.

Via Business Wire

3 Stock-Split Stocks With 51% to 128% Upside in 2024, According to Select Wall Street Analysts ↗

December 18, 2023

Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are three high-flying stocks a trio of Wall Street analysts believe can soar in the...

Via The Motley Fool

Pet Parents Keep Spending ↗

December 13, 2023

We also talk with Dexcom CEO Kevin Sayer about the impact of weight loss drugs on diabetes care.

Via The Motley Fool

DEXCOM INC (NASDAQ:DXCM) showing high EPS and FCF growth while beating expectations ↗

December 13, 2023

DEXCOM INC (NASDAQ:DXCM) may be suited for growth investing, we'll explore why in this article.

Via Chartmill

Is NASDAQ:DXCM on the Verge of a Major Breakout as a Strong Growth Stock? ↗

December 12, 2023

DEXCOM INC (NASDAQ:DXCM) qualifies as a high growth stock and is consolidating.

Via Chartmill

NASDAQ:DXCM is showing decent growth, but is still valued reasonably. ↗

December 11, 2023

NASDAQ:DXCM is not too expensive for the growth it is showing.

Via Chartmill

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,800 Today ↗

December 07, 2023

Via Benzinga

Dexcom G7 is Now the Most Accurate, Smallest, Easy-to-Use CGM Connected to the Tandem t:slim X2 Insulin Pump

December 06, 2023

From DexCom, Inc.

Via Business Wire

(DXCM) - Analyzing DexCom's Short Interest ↗

December 06, 2023

Via Benzinga

Market Whales and Their Recent Bets on DXCM Options ↗

December 05, 2023

Via Benzinga

Analyst Expectations for DexCom's Future ↗

December 04, 2023

Via Benzinga

Is NASDAQ:DXCM a Fit for Growth Investing Strategies? ↗

November 22, 2023

Is DEXCOM INC (NASDAQ:DXCM) suited for growth investing?

Via Chartmill

Here's How Much $100 Invested In DexCom 15 Years Ago Would Be Worth Today ↗

November 20, 2023

Via Benzinga

DexCom Stock Earns Healthy Relative Strength Rating Upgrade ↗

December 05, 2023

In a welcome move, medical device maker DexCom stock saw its Relative Strength Rating rise from 70 to 77 on Tuesday.

Via Investor's Business Daily

1 Stock-Split Stock to Buy Hand Over Fist in December, and 1 to Avoid Like the Plague ↗

December 04, 2023

Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there's a historically cheap outperformer, as well as an industry leader that could...

Via The Motley Fool

Investing $5,000 in These 3 Stocks Could Make You Rich ↗

November 27, 2023

Artificial intelligence should be a huge tailwind for all three of these stocks.

Via The Motley Fool

Topics Artificial Intelligence

Dexcom Announces Upcoming Conference Presentation

November 21, 2023

From DexCom, Inc.

Via Business Wire

Looking Into DexCom's Recent Short Interest ↗

November 17, 2023

Via Benzinga

Is DexCom the Next Big Growth Stock? ↗

November 17, 2023

It has significant growth drivers in play, but competitors are making inroads too.

Via The Motley Fool

Industry Comparison: Evaluating DexCom Against Competitors In Health Care Equipment & Supplies Industry ↗

November 16, 2023

Via Benzinga

3 Growth Stocks to Buy With $1,000 Right Now ↗

November 21, 2023

If you're having trouble finding your portfolio's next growth holding, here are three great options to choose from -- or you can choose all three.

Via The Motley Fool

Ozempic Might Be Helping Abbott Laboratories and DexCom Stock. Here's How. ↗

November 20, 2023

New medicines for weight loss and diabetes stand to disrupt the competitive scene.

Via The Motley Fool

3 Stock-Split Stocks Billionaires Are Buying Hand Over Fist ↗

November 20, 2023

Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are three industry-leading stocks that billionaire investors can't stop buying.

Via The Motley Fool

2 Stock Split Growth Stocks to Buy and Hold ↗

November 19, 2023

These companies could continue delivering excellent results long after their most recent stock splits are forgotten.

Via The Motley Fool

Investing Lesson: Value Drivers ↗

November 18, 2023

Trends come, trends go. So, how can investors spot the difference between another passing fad and something with real, sustainable value?

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

November 17, 2023

Via Benzinga

9 Health Care Stocks With Whale Alerts In Today's Session ↗

November 16, 2023

Via Benzinga

Could DexCom Stock Help You Become a Millionaire? ↗

November 16, 2023

DexCom has achieved strong growth over the years, but there's a big question mark over how strong it will be in the future.

Via The Motley Fool

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

43 44 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

DexCom, Inc. - Common Stock (NQ:DXCM)

All News about DexCom, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today